// App-Quantinova.ai

: Circulating tumor cells (CTCs) and plasma cell free DNA (cfDNA) androgen receptor amplification (ARamp)-based prognosis in metastatic castration-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Manish Kohli

Principal Investigators

  • Jian Li

  • Meijun Du

  • David W. Hillman

  • Winston Tan

  • Rachel Carlson

  • Liguo Wang

  • Liewei Wang

  • Minetta C. Liu

  • Huijuan Zhang

  • Peng Zhang

  • Liang Wang

Medical Centers

  • Mayo Clinic, Rochester, MN

  • The Medical College of Wisconsin, Milwaukee, WI

  • Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN

  • Mayo Clinic, Jacksonville, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • Plasma cell-free DNA

Drug/Treatment

  • CB-7598

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved